A PricewaterhouseCoopers report indicates that emerging countries like Brazil, India and China are emerging as leaders in medical innovation and may well surpass the U.S.
According to the report, medical technology innovators are more frequently going overseas to “seek clinical data, new-product registration and first revenue.” This may lead to a situation where Americans are the last to receive new medical technology. Emerging markets are quickly becoming “the leading markets for smaller, faster, more affordable devices that enable delivery of care anywhere and help bend the health-care cost curve downward.”
According to the report, the emerging nations are not hindered by “entrenched health-care system infrastructure that seeks to maintain the status quo.” The report’s co-author, a managing director at PwC, Christopher Wasden, said that it is important to “rethink our reimbursement system” to the medical tech industry. This may stimulate companies to stay in America.
Indian state-owned gas marketer GAIL? Ltd is searching to acquire shale gas companies in the US. Gail is prepared to invest approximately $400-500 million. The company has publicized a request for proposals (RFP) from bankers who are able to help it identify targets and to close a deal. The RFP was publicized last month.
In expectation of the increasing value of China’s currency, Manulife is launching several renminbi-based financial/insurance plans in Hong Kong. During the last five years, the RMB has increased twenty five percent against the dollar. Meanwhile, with China’s approval, Hong Kong has become the major offshore center for China’s currency. From January to November 2010, Renminbi deposits increased by 240% to Rmb2.2 trillion which is $32.9 billion.
Seoul Stocks declined yesterday after Wall Street fell based on fears about European Government debts. Samsung and Hana Financial Group dropped and the Korea Composite Stock Price Index .KS11 (Kospi) fell 0.87 % to 2,062.73 points. Also, on Thursday, the Bank of Korea will review the interest rates. Meanwhile, the chemical industries are still doing well.
CG Foods, a division of the Cinnovation Group from Singapore, said it will invest Rs.100 crore over the next three years to enlarge its manufacturing capacity in India.
Due to the government’s announcement that China will invest 700 Yuan ($106 Billion) in the railroads in 2011, the stocks of China’s two biggest train manufacturers, CSR Corp. and China CNR Corp., shot up in trading on the Shanghai market.